JS

JENNIFER STEGER

HORIZON GOVERNMENT AFFAIRS · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

4

last 3 years

Filings

15

4 agencies contacted

Activity

filings by quarter

Works on

Health Issues 12 Medicare/Medicaid 3

Background

Government experience

Scheduler/Legislative Assistant

Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach

Disclosed on LD-2 filings

Career

HG

HORIZON GOVERNMENT AFFAIRS

Washington, DC

2024 - present

Specific issues

Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.

Health Issues · 2024 Q4

Issues relating to Immunization Information System modernization, public health data modernization, and public health program reauthorization.

Health Issues · 2024 Q4

Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages, HR 3561, the PATIENT Act relating to transparency and reporting requirements, and HR 7623, the Telehealth Modernization Act of 2024 and HR 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act relating to transparency and reporting requirements.

Health Issues · 2024 Q3

Issues related to insurance agent and broker fees in Medicare, Proposed Rule-Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-P) and Final Rule - Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-F)

Medicare/Medicaid · 2024 Q3

Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages and the Patient Transparency bill (the Patient Act in house, the help and finance bills).

Health Issues · 2024 Q1

Issues related to insurance agent and broker fees in Medicare, Proposed Rule-Medicare Program; Contract Year 2025 Policy and Technical Changes (CMS-4205-P).

Medicare/Medicaid · 2024 Q1